111 related articles for article (PubMed ID: 27179719)
1. Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals.
Roberts JD; Hu D; Heckbert SR; Alonso A; Dewland TA; Vittinghoff E; Liu Y; Psaty BM; Olgin JE; Magnani JW; Huntsman S; Burchard EG; Arking DE; Bibbins-Domingo K; Harris TB; Perez MV; Ziv E; Marcus GM
JAMA Cardiol; 2016 Jul; 1(4):442-50. PubMed ID: 27438321
[TBL] [Abstract][Full Text] [Related]
2. The role of the renin-angiotensin system blocking in the management of atrial fibrillation.
Cliff B; Younis N; Hama S; Soran H
J Drug Assess; 2012; 1(1):55-64. PubMed ID: 27536429
[TBL] [Abstract][Full Text] [Related]
3. Investigating the RAS can be a fishy business: interdisciplinary opportunities using Zebrafish.
Hoffmann S; Mullins L; Buckley C; Rider S; Mullins J
Clin Sci (Lond); 2018 Dec; 132(23):2469-2481. PubMed ID: 30518571
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of the Renin Angiotensin system: effects on atherosclerosis in experimental models and humans.
Daugherty A; Poduri A; Chen X; Lu H; Cassis LA
Curr Atheroscler Rep; 2010 May; 12(3):167-73. PubMed ID: 20425255
[TBL] [Abstract][Full Text] [Related]
5. Discovery of rare variants for complex phenotypes.
Kosmicki JA; Churchhouse CL; Rivas MA; Neale BM
Hum Genet; 2016 Jun; 135(6):625-34. PubMed ID: 27221085
[TBL] [Abstract][Full Text] [Related]
6. GWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortium.
Matteini AM; Tanaka T; Karasik D; Atzmon G; Chou WC; Eicher JD; Johnson AD; Arnold AM; Callisaya ML; Davies G; Evans DS; Holtfreter B; Lohman K; Lunetta KL; Mangino M; Smith AV; Smith JA; Teumer A; Yu L; Arking DE; Buchman AS; Chibinik LB; De Jager PL; Evans DA; Faul JD; Garcia ME; Gillham-Nasenya I; Gudnason V; Hofman A; Hsu YH; Ittermann T; Lahousse L; Liewald DC; Liu Y; Lopez L; Rivadeneira F; Rotter JI; Siggeirsdottir K; Starr JM; Thomson R; Tranah GJ; Uitterlinden AG; Völker U; Völzke H; Weir DR; Yaffe K; Zhao W; Zhuang WV; Zmuda JM; Bennett DA; Cummings SR; Deary IJ; Ferrucci L; Harris TB; Kardia SL; Kocher T; Kritchevsky SB; Psaty BM; Seshadri S; Spector TD; Srikanth VK; Windham BG; Zillikens MC; Newman AB; Walston JD; Kiel DP; Murabito JM
Aging Cell; 2016 Oct; 15(5):792-800. PubMed ID: 27325353
[TBL] [Abstract][Full Text] [Related]
7. Rare coding TTN variants are associated with electrocardiographic QT interval in the general population.
Kapoor A; Bakshy K; Xu L; Nandakumar P; Lee D; Boerwinkle E; Grove ML; Arking DE; Chakravarti A
Sci Rep; 2016 Jun; 6():28356. PubMed ID: 27321809
[TBL] [Abstract][Full Text] [Related]
8. Endophenotype Network Models: Common Core of Complex Diseases.
Ghiassian SD; Menche J; Chasman DI; Giulianini F; Wang R; Ricchiuto P; Aikawa M; Iwata H; Müller C; Zeller T; Sharma A; Wild P; Lackner K; Singh S; Ridker PM; Blankenberg S; Barabási AL; Loscalzo J
Sci Rep; 2016 Jun; 6():27414. PubMed ID: 27278246
[TBL] [Abstract][Full Text] [Related]
9. Src-homology domain 2 containing protein tyrosine phosphatase-1 (SHP-1) directly binds to proto-oncogene tyrosine-protein kinase Src (c-Src) and promotes the transcriptional activation of connexin 43 (Cx43).
Liu Y; Dai M; Yang P; Cao L; Lu L
Bioengineered; 2022 May; 13(5):13534-13543. PubMed ID: 35659197
[TBL] [Abstract][Full Text] [Related]
10. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease.
Liu C; Lai Y; Wu D; Fu R; Li Y; Li H; Guan T; Shen Y
ESC Heart Fail; 2021 Dec; 8(6):5338-5351. PubMed ID: 34545695
[TBL] [Abstract][Full Text] [Related]
11. Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets.
Ding YH; Ma Y; Qian LY; Xu Q; Wang LH; Huang DS; Zou H
Oncotarget; 2017 Sep; 8(36):60673-60683. PubMed ID: 28948002
[TBL] [Abstract][Full Text] [Related]
12. Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction.
Arslan A; Ozaydin M; Aksoy F; Arslan B; Bas HA; Erdogan D; Varol E; Dogan A
Medicina (Kaunas); 2016; 52(2):104-9. PubMed ID: 27170483
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.
Horio T; Akiyama M; Iwashima Y; Yoshihara F; Nakamura S; Tokudome T; Okutsu M; Tanaka H; Komatsubara I; Okimoto N; Kamakura S; Kawano Y
J Hum Hypertens; 2017 Jul; 31(7):450-456. PubMed ID: 28032630
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
Zografos T; Katritsis DG
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
[TBL] [Abstract][Full Text] [Related]
15. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
[TBL] [Abstract][Full Text] [Related]
16. Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation.
Roberts JD; Dewland TA; Glidden DV; Hoffmann TJ; Arking DE; Chen LY; Psaty BM; Olgin JE; Alonso A; Heckbert SR; Marcus GM
Am Heart J; 2016 May; 175():9-17. PubMed ID: 27179719
[TBL] [Abstract][Full Text] [Related]
17. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
